Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-12-041282
Filing Date
2012-09-24
Accepted
2012-09-24 14:51:06
Documents
1
Period of Report
2012-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3553
  Complete submission text file 0001140361-12-041282.txt   4955
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALTUS PHARMACEUTICALS INC. 125 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Lieber Jonathan I (Reporting) CIK: 0001350090 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14656 | Film No.: 121106132